NHS warns furosemide users about dehydration risks, listing who should speak to a doctor, medicines to avoid, and how the ...

The NHS recommends eight key groups to inform their doctor prior to using the prescribed medication furosemide. This notably includes anyone exhibiting signs of dehydration, such as feeling thirsty, ...

The NHS recommends eight key groups to inform their doctor prior to using the prescribed medication furosemide. This notably includes anyone exhibiting signs of dehydration, such as feeling thirsty, ...

To ensure furosemide use is safe, the NHS advises eight key groups to tell a doctor before making use of the prescription ...

FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...

FUROSCIX is a registered trademark of scPharmaceuticals, a wholly owned subsidiary of MannKind Corporation. MANNKIND is a registered trademark of MannKind Corporation.

MannKind (Nasdaq:MNKD) announced that the FDA accepted a supplemental New Drug Application (sNDA) for its Furoscix ReadyFlow autoinjector. The Furoscix ReadyFlow autoinjector (SCP-111) was developed ...

Lasix Onyu (furosemide injection) Loop diuretic Treatment of edema in adult patients with chronic heart failure. FDA Approves Lasix ONYU, a Novel Furosemide Delivery Device Rybelsus (semaglutide) ...

Introduction: Furosemide (FUR) remains the cornerstone agent to decongest patients with heart failure. Given the challenges associated with intravenous (IV) administration, an 80mg/10mL buffered ...